US 12344677
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 12344677 (Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00